Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Adamis Pharmaceuticl (ADMP)

Adamis Pharmaceuticl (ADMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Adamis: Q2 Earnings Snapshot AP - Mon Aug 21, 2023

Adamis: Q2 Earnings Snapshot

ADMP : 0.7751 (+0.86%)
Adamis: Q1 Earnings Snapshot AP - Mon May 15, 2023

Adamis: Q1 Earnings Snapshot

ADMP : 0.7751 (+0.86%)
ADAMIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adamis Pharmaceuticals Corporation - ADMP Business Wire - Fri Mar 3, 2023

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Adamis Pharmaceuticals Corporation (the “Company”)...

ADMP : 0.7751 (+0.86%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Adamis Pharmaceuticals Corp. - ADMP PR Newswire - Wed Mar 1, 2023

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

ADMP : 0.7751 (+0.86%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, BTE, ADMP, VBLT PR Newswire - Tue Feb 28, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ROCC : 37.47 (-1.96%)
BTE : 3.73 (+2.19%)
ADMP : 0.7751 (+0.86%)
VBLT : 5.4600 (-8.77%)
ADMP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Adamis Pharmaceuticals Corporation Is Fair to Shareholders Business Wire - Tue Feb 28, 2023

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) and DMK Pharmaceuticals, Corp. is fair to Adamis shareholders.

ADMP : 0.7751 (+0.86%)
Wall Street - New York Stock Exchange NYSE
Stocks Mixed Before The Open As Fed Fears Persist, Target Earnings On Tap Barchart - Tue Feb 28, 2023

March S&P 500 futures (ESH23) are trending up +0.07% this morning after three major U.S. benchmark indices ended the regular session higher as investors digested an early round of U.S. economic data and...

ESH23 : 3,957.05s (-0.09%)
TSLA : 145.73 (+2.59%)
SGEN : 228.74 (-0.07%)
UNP : 236.39 (+0.82%)
ZM : 60.51 (+1.63%)
WDAY : 256.95 (+1.35%)
TGT : 166.23 (-0.53%)
MNST : 53.30 (-0.56%)
HPQ : 27.75 (+0.18%)
RIVN : 9.12 (+3.75%)
NCLH : 19.23 (+3.72%)
BAYN.D.DX : 27.317 (-0.23%)
Adamis: Q3 Earnings Snapshot AP - Mon Nov 14, 2022

Adamis: Q3 Earnings Snapshot

ADMP : 0.7751 (+0.86%)
Adamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update Globe Newswire - Wed Aug 10, 2022

Management to host webcast/conference call today at 1:30 p.m. PT / 4:30 p.m. ...

ADMP : 0.7751 (+0.86%)
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update Globe Newswire - Mon Aug 8, 2022

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and...

ADMP : 0.7751 (+0.86%)

Barchart Exclusives

Bottom 100 Stocks to Buy: Very Aggressive Investors Might Consider a Small Wager on This Class Action Stock Barchart - 1 hour ago
Sonder Holdings faces a potential class action lawsuit over the handling of its financial statements in 2022 and 2023. The penny stock has lost nearly 60% of its value over the past year and is in Barchart’s Bottom 100 Stocks to Buy. Yet, it could be a moneymaker for aggressive investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot